Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L de Vos

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Journal of Neuro-Oncology|October 18, 2017
Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysisJoeky T Senders, Nicole H Goldhaber, David J Cote, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2004
Long-term survivors of ovarian malignancies after cisplatin-based chemotherapy; cardiovascular risk factors and signs of vascular damageF Y F L de Vos, J Nuver, P H B Willemse, et al.
Critical Reviews in Oncology/Hematology|July 17, 2012
Menopausal status and adjuvant hormonal therapy for breast cancer patients: a practical guidelineF Y F L De Vos, H W M van Laarhoven, J S E Laven, et al.
Neuro-Oncology Practice|May 14, 2026
Clinical impact of [<sup>18</sup>F]FET-PET/CT in differentiating treatment-associated changes and tumor progression in adult-type diffuse gliomasVeerle J Ruijters, Anass El Ghalbouni, Arthur J A T Braat, et al.
European Journal of Cancer (Oxford, England : 1990)|January 13, 2006
Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with 5-fluorouracil and leucovorin: a safe combinationR Hoekstra, F Y F L de Vos, F A L M Eskens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Phase I trial with BMS-275183, a novel oral taxane with promising antitumor activityLinda E Bröker, Filip Y F L de Vos, Cees J van Groeningen, et al.
Journal of Neurology|November 19, 2020
Cognitive impairments are independently associated with shorter survival in diffuse glioma patientsEmma van Kessel, Irene M C Huenges Wajer, Carla Ruis, et al.
Frontiers in Neurology|December 6, 2021
Added Value of Cognition in the Prediction of Survival in Low and High Grade GliomaEmma van Kessel, Ewoud Schuit, Irene M C Huenges Wajer, et al.
Journal of Neuro-Oncology|May 11, 2023
Brain metastases in adult patients with melanoma of unknown primary in the Netherlands (2011-2020)C S Padilla, V K Y Ho, T W A N Mooijenkind, et al.
BMC Health Services Research|October 1, 2025
Timely integration of palliative care into oncology in hospitals in the Netherlands: a feasibility studyCarly S Heipon, Linda Brom, Wendy M van der Deure, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Journal of Neuro-Oncology|October 18, 2017
Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysisJoeky T Senders, Nicole H Goldhaber, David J Cote, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2004
Long-term survivors of ovarian malignancies after cisplatin-based chemotherapy; cardiovascular risk factors and signs of vascular damageF Y F L de Vos, J Nuver, P H B Willemse, et al.
Critical Reviews in Oncology/Hematology|July 17, 2012
Menopausal status and adjuvant hormonal therapy for breast cancer patients: a practical guidelineF Y F L De Vos, H W M van Laarhoven, J S E Laven, et al.
Neuro-Oncology Practice|May 14, 2026
Clinical impact of [<sup>18</sup>F]FET-PET/CT in differentiating treatment-associated changes and tumor progression in adult-type diffuse gliomasVeerle J Ruijters, Anass El Ghalbouni, Arthur J A T Braat, et al.
European Journal of Cancer (Oxford, England : 1990)|January 13, 2006
Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with 5-fluorouracil and leucovorin: a safe combinationR Hoekstra, F Y F L de Vos, F A L M Eskens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Phase I trial with BMS-275183, a novel oral taxane with promising antitumor activityLinda E Bröker, Filip Y F L de Vos, Cees J van Groeningen, et al.
Journal of Neurology|November 19, 2020
Cognitive impairments are independently associated with shorter survival in diffuse glioma patientsEmma van Kessel, Irene M C Huenges Wajer, Carla Ruis, et al.
Frontiers in Neurology|December 6, 2021
Added Value of Cognition in the Prediction of Survival in Low and High Grade GliomaEmma van Kessel, Ewoud Schuit, Irene M C Huenges Wajer, et al.
Journal of Neuro-Oncology|May 11, 2023
Brain metastases in adult patients with melanoma of unknown primary in the Netherlands (2011-2020)C S Padilla, V K Y Ho, T W A N Mooijenkind, et al.
BMC Health Services Research|October 1, 2025
Timely integration of palliative care into oncology in hospitals in the Netherlands: a feasibility studyCarly S Heipon, Linda Brom, Wendy M van der Deure, et al.
Pageof 11